Journal of Global Pharma Technology
Volume 12 Issue 04 (2020) April 2020

Interleukin (IL) 18 and Its Relation with Diabetes Mellitus and Chronic Periodontitis

Kavitha J (DR.J.KAVITHA MDS ASSOCIATE PROFESSOR Department of Periodontia, RMDCH, Annamalai University. kavithajayavel@gmail.com)



Article Info

Publish Date
05 Apr 2020

Abstract

 IL-18 is a member of the IL-1 family of cytokines. IL-18 demonstrates a unique function by binding to a specific receptor expressed on various types of cells. Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Metabolic abnormalities in carbohydrates, lipids, and proteins result from the importance of insulin as an anabolic hormone. Chronic periodontitis, also known as adult periodontitis, is an infectious inflammatory disease caused by the bacteria of the dental plaque, resulting in the progressive destruction of the tissues that support the teeth, i.e. the gingival, the periodontal ligament, cementum, and the alveolar bone. Chronic periodontitis can also play a role as a metabolic stress or for diabetes control. In this review article, we will focus on the unique features of Interleukin (IL) 18 and its relation with diabetes mellitus and chronic periodontitis.

Copyrights © 2020






Journal Info

Abbrev

jgpt

Publisher

Subject

Medicine & Pharmacology

Description

ournal of Global Pharma Technology is a monthly, open access, Peer review journal of Pharmacy published by JGPT Journal publishes peer-reviewed original research papers, case reports and systematic reviews. The journal allows free access to its contents, which is likely to attract more readers and ...